Timetable

Parallel Plenary Satellite Symposium Workshop Poster

Thursday, 22 October 2009
17:00	01Janssen Cilag Sponsored Welcome Reception Ballroom Le Grand 3
18:00	02Janssen Cilag Sponsored Dinner and Satellite Symposium Ballroom Le Grand 3 Cognitive Dysfunction in Bipolar Disorder: Implications for Pharmacotherapy and Psychotherapy Dr Joseph Goldberg, New Canaan, CT, United States
20:00

Friday, 23 October 2009
07:00	14Pfizer Sponsored Breakfast and Satellite Symposium Ballroom Le Grand 3 Metabolic syndrome and other comorbid medical conditions in bipolar disorder Prof John Tiller, The University of Melbourne Lifestyle Management of Bipolar Disorder Prof Michael Berk, Barwon Health, University of Melbourne
08:30
09:15	04Welcome Address Ballroom Le Grand 3
09:30	05Stabilising Mood: 60 Years of Progress Ballroom Le Grand 3 Stabilising Mood: 60 Years of Progress Prof Gordon Johnson, University of Sydney and Director, Mood Disorders Unit Northside Clinic
10:15	06Antidepressant Controversies in the Treatment of Bipolar Depression Ballroom Le Grand 3 Antidepressant Controversies in the Treatment of Bipolar Depression Dr Joseph Goldberg, New Canaan, CT, United States
11:00
11:30	07Phenomenology Ballroom Le Grand 1 Partitioning Mood Using fMRI Prof Gin S Malhi, Discipline of Psychological Medicine, University of Sydney, Sydney, Australia Investigation of Biopterin Deficit in Bipolar Disorder Dr Catherine L Clelland, Columbia University, United States Bipolar disorder in australia: the 2007 national survey of mental health and well-being Philip Mitchell, University of New South Wales; Black Dog Institute; and National Drug and Alcohol Research Centre	08Treatment Ballroom Le Grand 3 Randomized controlled trial of olanzapine or chlorpromazine as addition to lithium in the treatment of a first manic episode with psychotic features: an 8 weeks, flexible dose, single blind trial Prof Michael Berk, Department of Clinical and Biomedical Sciences: Barwon Health, University of Melbourne, Geelong, Australia From RCT to clinical practice: Implementing and evaluating an effective relapse prevention program for bipolar disorder in community settings Ms Carolynne White, Frameworks for Health, St Vincent's Hospital (Melbourne) Manic and depressive symptom exacerbation as a function of interaction of dysfunctional attitudes with life events Ms Anet Babakhani, The University of Newcastle
12:30	19ASBD Annual General Meeting Ballroom Le Grand 3	P1Poster Session Ann Street Lobby Celebrating the consumer movement of people living with bipolar disorder A/Prof Meg A Smith, University of Western Sydney Facing Potential Bipolar Disorder? N170 Event-Related Potential Variances During Emotional Face Processing in Bipolar Disorder Racheal Degabriele, Department of Psychological Medicine, The University of Sydney Validity of a paediatric quality of life questionnaire for participants with juvenile bipolar disorder Dr Edward H Clayton, NSW Department of Primary Industries, Wagga Wagga Agricultural Institute, Wagga Wagga, NSW Australia Attachment theory and trauma in the paediatric bipolar disorder literature Dr Peter I Parry, Flinders University Predictors of engagement in psychological therapy for first episode bipolar disorder Dr Melissa K Hasty, Orygen Youth Health Bipolar Disorder is associated with a higher dietary glycemic load Prof Michael Berk, University of Melbourne Randomized, Placebo-controlled, Long-term Study of Risperidone Long Acting Injectable in Relapse Prevention in Bipolar Disorder Patients Matthias Skillecorn, Janssen Cilag Development of Guidelines For Carers of Adults with Bipolar Disorder Dr Seetal Dodd, Department of Clinical and Biomedical Sciences University of Melbourne Does tobacco smoking make bipolar disorder worse? Evidence from clinical studies Dr Seetal Dodd, Department of Clinical and Biomedical Sciences University of Melbourne
13:00
14:00	09What are the limits of psychological interventions in bipolar disorder? Ballroom Le Grand 3 What are the limits of psychological interventions in BD?? Dr Francesc Colom, Institute of Neurosciences, Hospital Clinic, Spain
14:45	10Recovery from bipolar disorder episode- what does it really mean and what does it look like? Ballroom Le Grand 3 Recovery from bipolar disorder episode- what does it really mean and what does it look like? Dr Roy Chengappa, Department of Psychiatry at the University Of Pittsburgh School Of Medicine and the Western Psychiatric Institute and Clinic, United States
15:30
16:00	11Juvenile and Adolescent Bipolar Disorder Ballroom Le Grand 1 Paediatric bipolar disorder: The view from Australia and New Zealand Dr Peter I Parry, Flinders University Evaluation of treatment outcomes from an Australian juvenile bipolar disorder clinic Mr Stephen J Hirneth, The Bipolar Program, Hunter New England Area Health Service, Newcastle, NSW, Australia An Investigation of the Relationship between Childhood Trauma and the 12-month Outcome of First Episode Mania in Adolescents and Young Adults Ms Rothanthi Daglas, ORYGEN Youth Health Research Centre	12Perinatal Bipolar Disorder Ballroom Le Grand 3 Bipolar Mood Disorder and Pregnancy - Risks and Recommendations Dr Jonathan G Rampono, Chairman, Physiological Medicine Clinical Care Unit, King Edward Memorial Hospital, WA Health Service PND and BIPOLARITY Dr Beverley Turner, VMO, CAMHS, Greater Western Area Health Service - NSW Health Improvement in Digit Span in Juvenile Bipolar Disorder Following Supplementation with Long Chain Omega-3 Polyunsaturated Fatty Acids Dr Tanya L Hanstock, The Bipolar Program, Hunter New England Area Health Service, Newcastle, NSW Australia
17:00
18:00	13Astra Zeneca Sponsored Dinner and Satellite Symposium Ballroom Le Grand 3 Mixed Mania Dr Roy Chengappa, Department of Psychiatry at the University Of Pittsburgh School Of Medicine and the Western Psychiatric Institute and Clinic, United States
20:00

Saturday, 24 October 2009
07:00	03Eli Lilly Sponsored Breakfast and Satellite Symposium Ballroom Le Grand 3 New Treatments in Bipolar Disorder Prof Gordon Parker, University of Sydney and Director, Blackdog Institute, Sydney Longterm Outcomes in Bipolar Disorder Prof Malcolm Hopwood, Austin Health, Victoria
08:30
09:15	15Bipolar Disorder and The Law Ballroom Le Grand 3 A Lawyer and Bipolar Disorder Greg Barns, Beyondblue Ambassador
10:00	16Glutathione and redox biology; from pathophysiology to novel treatments Ballroom Le Grand 3 Glutathione and redox biology; from pathophysiology to novel treatments Prof Michael Berk, Barwon Health, University of Melbourne
11:00
11:30	17Treatment and Outcomes in Bipolar Disorder Ballroom Le Grand 1 Staying well with bipolar disorder with a 'Stay Well Plan' Dr Sarah J Russell, Research Matters Prospective Relationships Between Activity, Sleep, and Mood in Outpatients with Bipolar Disorder: An Initial Step Towards the Application of Monitoring Technologies in the Clinical Setting Mr Ben Bullock, Swinburne University of Technology B-COS Gender Matters: Presenting the Profile of Females with Bipolar Disorder from an Australian Observational Study Kate Filia, The Alfred and Monash University The Use of Atypical Antipsychotics as Augmentation Therapy in Bipolar Disorder Prof Isaac Schweitzer, The Melbourne Clinic, University of Melbourne Quality of Life of Participants with Bipolar and Schizoaffective Disorder in an Australian Cohort after 24 months Sacha Filia, The Alfred and Monash University Two-Year Treatment Outcomes Of An Australian Outpatient Cohort With Bipolar I Or Schizoaffective Disorder Kate Filia, The Alfred and Monash University	18Workshop - Psychoeducation in Bipolar Disorders Ballroom Le Grand 3 The role of psychoeducation in Bipolar Disorders Dr Francesc Colom, Institute of Neurosciences, Hospital Clinic, Spain
13:30